Alison Hayes BVMS CertVR MSc (Clin Onc) DipECVIM-CA (Oncology) PGCert(MedEd) AFHEA MRCVS
RCVS Recognised Specialist in Veterinary Oncology
EBVS® European Veterinary Specialist in Small Animal Oncology
Associate Principal Oncologist
Biography
Dr Alison Hayes is an EBVS European and RCVS Recognised Veterinary Specialist in Small Animal Oncology and a European College of Veterinary Internal Medicine (ECVIM) Foundation Diplomate. Alison is an Associate Teaching Professor and holds the post of Associate Principal Oncologist. Alison is responsible for running the referral oncology clinics at the Queens Veterinary School Hospital at the University of Cambridge, is an Associate Fellow of the Higher Education Authority, a supervisor for the ECVIM Oncology residency programme, a member of the Scientific Committee for the European Society of Veterinary Oncology (ESVONC) and ECVIM congresses, and former ESVONC treasurer.
Alison graduated from the University of Glasgow and after five years in primary care practice undertook the inaugural Blue Cross Residency in Oncology at the Animal Health Trust, Newmarket and Master’s degree in Clinical Oncology (distinction) at the Medical School, University Birmingham. Alison remained at the Trust as Senior Clinical Oncologist and after a period of time working in the charitable sector for national children’s charity, Alison joined the University of Cambridge in 2020. As well as all things oncological, Alison has a strong interest in veterinary education, human factors and communication, and is the Clinical Skills Champion for the Pauline Brown Clinical Skills Centre at the QVSH.
Alison is co-chair of the Quality Improvement and Clinical Governance Group at the QVSH and has recently completed the Post Graduate Certificate in Medical Education (distinction) at the Institute for Continuing Education, University of Cambridge. Alison is a Veterinary Student Clinical Supervisor (VSCS) at Magdalene College, Cambridge.
Research
Canine transmissible venereal tumour, canine nasal tumours, feline oral tumours, lymphoma.
Publications
Gori, Kevin C., et al. "Horizontal transfer of nuclear DNA in transmissible cancer." bioRxiv (2024): 2024-07.
Hayes, A., Hughes, K., Hare, C., Peschard, L., Lara, A.S., Schiavo, L. and Dobson, J., 2023. T-cell lymphoma involving the rectum of a dog. Journal of Comparative Pathology, 207, pp.87-90.
Hayes AM, Schiavo L, Constantino-Casas F, Desmas I, Dobson J, Draper A, Elliot J, Genain M-A, Wang J, Murchison EP. Transmission of canine transmissible venereal tumour between two dogs in the United Kingdom. J Small Anim Pract. 2023 Mar 29. doi: 10.1111/jsap.13607.
Berry A, Hayes AM, Dobson JM. Multimodal Treatment of a Canine Lingual Melanoma using a Combination of Immunotherapy and a Tyrosine Kinase Inhibitor. Vet. Sci. 2022, 9(2), 54; https://doi.org/10.3390/vetsci9020054
Van den Steen N, Berlato D, Polton G, Dobson J, Stewart J, Maglennon G, Hayes AM, Murphy S. Rectal lymphoma in 11 dogs: a retrospective study. J Small Anim Pract. 2012 Oct;53(10):586-91
Bommer NX, Hayes AM, Scase TJ, Gunn-Moore DA. Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam. J Feline Med Surg. 2012 Aug;14(8):527-33.
Bergkvist GT, Argyle DJ, Morrison L, MacIntyre N, Hayes A, Yool DA. Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC) Vet Comp Oncol. 2011 Jun;9(2):106-17.
Busse C, Sansom J, Dubielzig RR, Hayes A. Corneal squamous cell carcinoma in a Border Collie. Vet Ophthalmol. 2008 Jan-Feb;11(1):55-8.
Hayes A, Adams V, Smith K, Maglennon G, Murphy S. Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours. Vet Comp Oncol. 2007 Sep;5(3):168-76.
Hayes AM, Adams VJ, Scase TJ, Murphy S. Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice. J Small Anim Pract. 2007 Jul;48(7):394-9.
Hayes AM, Gregory SP, Murphy S, McConnell JF, Patterson-Kane JC. Solitary extramedullary plasmacytoma of the canine larynx. J Small Anim Pract. 2007 May;48(5):288-91.
Hayes A Feline lymphoma 2. Specific disease presentations. In Practice 2006, 28, 578-585
Hayes A. Feline lymphoma 1. Principles of diagnosis and management. In Practice 2006, 28, 516-524.
Goodfellow M, Hayes A, Murphy S, Brearley M. A retrospective study of (90)Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum. J Feline Med Surg. 2006 Jun;8(3):169-76.
Hayes A, Scase T, Miller J, Murphy S, Sparkes A, Adams V. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol. 2006 Aug-Oct;135(2-3):93-99.
McConnell JF, Hayes A, Platt SR, Smith KC. Calvarial hyperostosis syndrome in two bullmastiffs. Vet Radiol Ultrasound. 2006 Jan-Feb;47(1):72-7.
Murphy S, Hayes A, Adams V, Maglennon G, Neath P, Ladlow J, Brearley MJ. Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma--a case series of five dogs. J Small Anim Pract. 2006 Apr;47(4):216-20.
Hayes A. Safe use of anticancer chemotherapy in small animal practice. In Practice 2005, 27, 118-127
Murphy S, Hayes AM, Blackwood L, Maglennon G, Pattinson H, Sparkes AH. Oral malignant melanoma - the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy. Vet Comp Oncol. 2005 Dec;3(4):222-9.
Hayes AM, Dennis R, Smith KC, Brearley MJ. Synovial myxoma: magnetic resonance imaging in the assessment of an unusual canine soft tissue tumour. J Small Anim Pract. 1999 Oct;40(10):489-94.
Brearley MJ, Hayes AM, Murphy S. Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: a retrospective analysis of survival. J Small Anim Pract. 1999 May;40(5):206-10.
